Tag: Ibogaine

A new executive order could position the US territory as a research destination for emerging psychedelic therapies as clinicians, researchers ...

When Eli Lilly agreed to acquire Atai Beckley in a deal worth up to US$3.8 billion, it wasn't simply the ...

While psilocybin and MDMA have dominated the modern psychedelic renaissance, another compound has quietly remained on the sidelines. Ibogaine has ...